Novo Nordisk's Negelle Morris spoke exclusively with ABC News.
and Wegovy, says the company is investing over $6 billion dollars to help meet the increased demand for the drugs amid
Novo Nordisk told ABC News that despite the shortages for Wegovy, the company has enough product on the market to start 25,000 patients on Wegovy per week -- a fourfold increase since late last year. Without insurance coverage, the out-of-pocket cost for medications like Ozempic and Wegovy can run as high as $1,000 or more per month.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's OzempicThe agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.
Read more »
FTC challenges ‘junk' patents held by 10 drugmakers, including for Novo Nordisk's OzempicThe agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.
Read more »
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and Wegovy
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyA U.S. Senate committee said on Wednesday it had launched an investigation into the prices of Novo Nordisk's diabetes and weight loss drugs Ozempic and Wegovy in the United States.
Read more »